These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 835377)

  • 41. Prophylactic antiarrhythmic therapy in acute myocardial infarction.
    Campbell RW
    Am J Cardiol; 1984 Dec; 54(11):8E-10E. PubMed ID: 6150634
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Hemodynamic effects of combined treatment with lignocaine, procainamide and practolol in acute myocardial infarction.
    Nordlander R; Nyquist O
    Cardiology; 1980; 66(1):27-42. PubMed ID: 7388852
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Initiation of ventricular fibrillation by supraventricular beats in patients with acute myocardial infarction.
    Bekheit S; Turitto G; Fontaine J; el-Sherif N
    Br Heart J; 1988 Feb; 59(2):190-5. PubMed ID: 2449233
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Clinical aspects of ventricular fibrillation in the development of myocardial infarction].
    Ramírez A; Prieto ME; Peña C; Mejías M; Carrillo E
    Arch Inst Cardiol Mex; 1984; 54(3):259-65. PubMed ID: 6465998
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Electrophysiological and anatomic differences between canine hearts with inducible ventricular tachycardia and fibrillation associated with chronic myocardial infarction.
    Denniss AR; Richards DA; Waywood JA; Yung T; Kam CA; Ross DL; Uther JB
    Circ Res; 1989 Jan; 64(1):155-66. PubMed ID: 2909298
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Ventricular tachyarrhythmias and lignocaine prophylaxis in acute myocardial infarction. A clinical and therapeutic study.
    Mogensen L
    Acta Med Scand Suppl; 1970; 513():1-80. PubMed ID: 5288550
    [No Abstract]   [Full Text] [Related]  

  • 47. Prevalence and prognosis of ventricular tachycardia/ventricular fibrillation in patients with post-infarction left ventricular aneurysm: Analysis of 575 cases.
    Ning X; Ye X; Si Y; Yang Z; Zhao Y; Sun Q; Chen R; Tang M; Chen K; Zhang X; Zhang S
    J Electrocardiol; 2018; 51(4):742-746. PubMed ID: 29803411
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Ventricular arrhythmias in the acute stage of experimental swine myocardial infarct; effect of the beta blocker pindolol and the calcium antagonist Ro 11-1781].
    Frank J; Dolder M; Gertsch M; Althaus U; Gurtner HP
    Schweiz Med Wochenschr; 1978 Nov; 108(44):1740-3. PubMed ID: 715414
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Prophylactic lidocaine in the early phase of suspected myocardial infarction.
    Dunn HM; McComb JM; Kinney CD; Campbell NP; Shanks RG; MacKenzie G; Adgey AA
    Am Heart J; 1985 Aug; 110(2):353-62. PubMed ID: 3895875
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Efficacy of Nifekalant hydrochloride for life-threatening ventricular tachyarrhythmias in patients with resistance to lidocaine: a study of patients with out-of-hospital cardiac arrest].
    Amino M; Yoshioka K; Iwata O; Fujikura H; Deguchi Y; Ban K; Shiina Y; Goto S; Handa S; Tanabe T; Nakagawa Y; Morita S; Iwase H; Yamamoto I; Inokuchi S; Marutani Y
    J Cardiol; 2003 Mar; 41(3):127-34. PubMed ID: 12674997
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Prodromal ventricular premature beats preceded by a diastolic wave.
    Ejvinsson G; Orinius E
    Acta Med Scand; 1980; 208(6):445-50. PubMed ID: 7468313
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Evolving concepts of management of stable and potentially lethal arrhythmias.
    Myerburg RJ; Zaman L; Kessler KM; Castellanos A
    Am Heart J; 1982 Apr; 103(4 Pt 2):615-25. PubMed ID: 6175195
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Relation between the occurrence of malignant arrhythmia during acute myocardial ischemia and the weight of ischemic myocardium in goats].
    Zhang L; Li S; Liu Q; Luo H; Xiao J; Xue Z
    Hua Xi Yi Ke Da Xue Xue Bao; 1992 Sep; 23(3):297-300. PubMed ID: 1298721
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Risk-benefit stratification as a guide to lidocaine prophylaxis of primary ventricular fibrillation in acute myocardial infarction: an analytic review.
    Goldman L; Batsford WP
    Yale J Biol Med; 1979; 52(5):455-66. PubMed ID: 392960
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Electrophysiologic characteristics of ventricular tachycardia or fibrillation in relation to age of myocardial infarction.
    Stevenson WG; Brugada P; Kersschot I; Waldecker B; Zehender M; Geibel A; Wellens HJ
    Am J Cardiol; 1986 Feb; 57(6):387-91. PubMed ID: 3946252
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [New aspects of the clinical use of anti-arrhythmia agents with special reference to acute therapy of ventricular tachycardia (lidocaine vs. ajmaline)].
    Manz M; Mletzko R; Jung W; Lüderitz B
    Herz; 1990 Apr; 15(2):79-89. PubMed ID: 2188894
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Ventricular arrhythmias during coronary angiography in patients with angina pectoris or chest pain syndromes.
    Nishimura RA; Holmes DR; McFarland TM; Smith HC; Bove AA
    Am J Cardiol; 1984 Jun; 53(11):1496-9. PubMed ID: 6731292
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Sustained ventricular tachycardia and ventricular fibrillation complicating non-ST-segment-elevation acute coronary syndromes.
    Piccini JP; White JA; Mehta RH; Lokhnygina Y; Al-Khatib SM; Tricoci P; Pollack CV; Montalescot G; Van de Werf F; Gibson CM; Giugliano RP; Califf RM; Harrington RA; Newby LK
    Circulation; 2012 Jul; 126(1):41-9. PubMed ID: 22645292
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Relationship between an arrhythmogenic action of lidocaine and its effects on excitation patterns in acutely ischemic porcine myocardium.
    Carson DL; Cardinal R; Savard P; Vasseur C; Nattel S; Lambert C; Nadeau R
    J Cardiovasc Pharmacol; 1986; 8(1):126-36. PubMed ID: 2419674
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Prospective evaluation of a discriminant function for prediction of recurrent symptomatic ventricular tachycardia or ventricular fibrillation in coronary artery disease patients receiving amiodarone and having inducible ventricular tachycardia at electrophysiologic study.
    Klein LS; Fineberg N; Heger JJ; Miles WM; Kammerling JM; Chang MS; Zipes DP; Prystowsky EN
    Am J Cardiol; 1988 May; 61(13):1024-30. PubMed ID: 3364357
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.